Bristol-Myers Squibb Company (NYSE:BMY) is included among the 14 Best Low Volatility Dividend Stocks to Invest in. On February 20, Barclays began coverage of Bristol-Myers Squibb Company (NYSE:BMY) ...

FDA-approved Andexxa reversed Xarelto and Eliquis bleeding but was linked to higher rates of blood clots and death, ...

CRISPR Therapeutics stays a Hold as CASGEVY launch lags; watch cash burn, revenue delays, and CTX310/CTX611 catalysts for 2026. Click here to read now.

Editor’s Note: The story has been updated with comments from J&J The National Institutes of Health (NIH) on Tuesday discontinued the low-dose rivaroxaban arm of its ongoing Phase 3 CAPTIVA stroke ...

Cardiologists suggest reaching into your fridge and pantry before your medicine cabinet. "Focus on a 'food first' approach," ...

BMY's legacy drugs see sharp generic erosion in 2026, but Eliquis growth and guidance shape expectations as competition heats ...

Bayer announced on Thursday that its experimental blood thinner has been proven to reduce the risk of stroke recurrence by 26% in late-stage trials, providing fresh impetus to CEO Bill Anderson's ...

Bristol Myers Squibb on Thursday forecast 2026 revenue and profit above Wall Street estimates, saying that price cuts to its blood thinner Eliquis will help drive up revenue, and shares of the U.S.

OKLAHOMA CITY (KFOR) — Dr. Melinda Cail with Primary Health Partners joined us in the KFOR studio on Thursday to tell us about the good and the bad that come with taking blood thinners. People say ...

Larry Bordeaux, 65, has been on blood thinners since 2010, after he started developing deadly clots following an operation. He credits the drugs with saving his life. If he stops taking them for ...